– Transformational year ahead with critical Phase 2 readouts expected for programs in hepatitis B, hepatitis D and influenza with…
Expansion of the AER-901 development program to include pulmonary hypertension associated with interstitial lung disease (PH-ILD) builds on the company’s…
Study Reveals 50% of respondents in leadership roles catch incidents of field reps using unapproved content, but a continuous learning…
First-of-its-kind collaboration between Boise State, a leading public university and HFMA, a major professional association, is recognized by the Commission…
The leading virtual Opioid Use Disorder treatment provider will fill gaps in care for formerly incarcerated patients struggling with opioid…
BUFFALO, N.Y., Feb. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to…
Preclinical data demonstrate potential to orally deliver peptides and monoclonal antibodies at bioavailability levels more than double the company’s current…
Company Launches a New Educational Campaign For ProvidersMALVERN, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a…
STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action…
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today…